Article Details

Intellia Announces First Clinical Evidence from Ongoing - GlobeNewswire

Retrieved on: 2024-11-16 15:31:31

Tags for this article:

Click the tags to see associated articles and topics

Intellia Announces First Clinical Evidence from Ongoing - GlobeNewswire. View article details on hiswai:

Excerpt

Nex-z is an investigational in vivo CRISPR-based gene editing therapy in development as a one-time treatment for ATTR amyloidosis. Development and ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up